Related references
Note: Only part of the references are listed.Prevalence and Costs of Skin Cancer Treatment in the US, 2002-2006 and 2007-2011
Gery P. Guy et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2015)
Inhibition of 11β-Hydroxysteroid Dehydrogenase Type II Suppresses Lung Carcinogenesis by Blocking Tumor COX-2 Expression as Well as the ERK and mTOR Signaling Pathways
Jian Chang et al.
PLOS ONE (2015)
Non-Melanoma Skin Cancer Incidence and Impact of Skin Cancer Screening on Incidence
Nora Eisemann et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
RNASEL and MIR146A SNP-SNP Interaction as a Susceptibility Factor for Non-Melanoma Skin Cancer
Shohreh F. Farzan et al.
PLOS ONE (2014)
Changing glucocorticoid action: 11β-Hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation
Karen E. Chapman et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Non-melanoma skin cancer: carcinogenesis and chemoprevention
Andrew C. Chen et al.
PATHOLOGY (2013)
Skin Cancer: An Overview of Epidemiology and Risk Factors
Randy Gordon
Seminars in Oncology Nursing (2013)
Structure, function and regulation of the DNA-binding protein Dps and its role in acid and oxidative stress resistance in Escherichia coli: a review
L. N. Calhoun et al.
JOURNAL OF APPLIED MICROBIOLOGY (2011)
In silico structure-function analysis of pathological variation in the HSD11B2 gene sequence
Jonathan R. Manning et al.
PHYSIOLOGICAL GENOMICS (2010)
Inhibition of 11 beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans
Ming-Zhi Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Can licorice lick colon cancer?
Paul M. Stewart et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications
Erika L. Abel et al.
NATURE PROTOCOLS (2009)
NAD dependent 11 beta-hydroxysteroid dehydrogenase activity in human endometrium and endometrial tumors
Tsatsas Manolis et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2006)
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma:: results from a randomized vehicle-controlled phase III study in Europe
HJ Schulze et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Impairment of the antiproliferative effect of glucocorticosteroids by 11β-hydroxysteroid dehydrogenase type 2 overexpression in MCF-7 breast-cancer cells
C Lipka et al.
HORMONE AND METABOLIC RESEARCH (2004)
11β-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action:: from metabolism to memory
JR Seckl et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation
HS Yang et al.
ONCOGENE (2003)
11β-hydroxysteroid dehydrogenases, cell proliferation and malignancy
EH Rabbitt et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Prereceptor regulation of glucocorticoid action by 11 beta-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation
EH Rabbitt et al.
FASEB JOURNAL (2002)
Expression of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in breast tumors and modulation of activity and cell grow-th in PMC42 cells
K Koyama et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2001)